toppbild-investerare-1551x278.jpg

Board of directors

	Jonas Ekblom Executive Chairman Born 1965. Active in the company since 2024. Jonas has a bachelor's degree in chemistry from Stockholm University, a doctorate in medical sciences from Uppsala University and a postdoctoral education from the University of Southern California in Los Angeles, USA. Since 1996, Jonas holds an associate professorship in pharmacology at Uppsala University. Jonas has worked for three decades in research and development of pharmaceutical and medtech products. Jonas has held board and management positions in public and privately held life science companies in Sweden, Switzerland and the USA. He has served as CEO of BOWS Pharmaceuticals SA, Pergamum AB and Promore Pharma AB. Today, Jonas is chairman of the board in Oblique Therapeutics AB (publ.) and partner in Ekblom & Denissenko. Shareholding: 0 shares. Independent in relation to the company and the owners.
	Isabelle Ducellier Born 1969. Active in the company since 2025. Isabelle Ducellier is a dual citizen of France and Sweden. She has over 30 years of experience in building global brands in highly international environments. She began her career in the wine and spirits industry but has focused on consumer health since 2017. She has served as Secretary General of the Swedish Childhood Cancer Fund, CEO of the world-leading probiotic company BioGaia, and most recently CEO of Orkla Health—a key European player in VMS (Vitamins, Minerals, and Supplements), oral health, and a global manufacturer of wound care and first aid products. Shareholding: 5751 shares. Independent in relation to the company and the owners.
	Otto Skolling Born 1961. Active in the company since 2025. Otto has over 30 years of experience in product development, business development, and project management in the pharmaceutical and medical technology industries, with leading roles at companies such as Novozymes, Siemens Life Support Systems, and Pharmacia Upjohn. He has also been the chairman of the board at Volusense AS and a board member at several companies including Asarina Pharma AB and Nanexa AB. Otto holds a master's degree in chemical engineering from KTH. Otto is currently the chairman of the board at Chordate Medical Holding AB and Pharmor AB, as well as a board member at Lipidor AB, Respinor AB (Publ), and Isles of Wines AB. He also works with business development for Dilafor AB. Shareholding: 0 shares. Independent in relation to the company.
	Nikolaj Sørensen Born 1972. Board members since 2021. Nikolaj Sörensen has more than 20 years of experience from the life science and the pharmaceutical industry in Sweden and abroad. Nikolaj today serves as President and CEO of Orexo AB. Previous appointments includes senior management positions at Pfizer and as management consultant at the Boston Consulting Group (BCG). Nikolaj has a M.Sc. in International Business from Copenhagen Business School. Nikolaj is Board member of Gesynta Pharma AB. Shareholding: 28 902 shares. independent from the company and the owners.
	Richard Ding Born 1982. Active in the company since 2025. Richard has more than 15 years of experience in global equity investment and maximizing shareholder value. Richard is also a serial entrepreneur who has co-founded, acquired and developed multiple businesses across finance, direct-to-consumer (DTC) goods, and healthcare. Richard currently serves as the CEO of How100.ai and Goldenwise Capital Group, as well as the Managing Director of BalanceGenics and The Stretching Institute of America. Richard holds an M.Sc. in Financial Mathematics from the University of British Columbia, Canada. Shareholding: 2.741.789 shares. Independent in relation to the company and the owners.
	Mona Zhang Born 1981. Active In the company since 2025. Mona holds an MBA from Rotman and a bachelor's degree in electrical engineering from Beijing Institute of Technology. Mona Zhang has more than 15 years of experience in global investment management and corporate governance. Mona is the Founder and Managing Partner of Trunity Partners Ltd., a portfolio management firm registered with the Ontario Securities Commission in Canada, where she is responsible for capital allocation, operations, and compliance. Previously, she worked at Mackenzie Investments as a Portfolio Manager on the Global Equity and Income Team, focusing on investment research, portfolio construction, and risk oversight. Earlier in her career, she was with Burgundy Asset Management, specializing in international equity analysis. Today, Mona serves on the Boards of the Canadian Business History Association and the International Agama Zen Practice Centre. She is also a guest lecturer at the Rotman School of Management, University of Toronto. She is a CFA charterholder. Shareholding: 0 shares. Independent in relation to the Company and the owners.
	Fredrik Blom Born 1970. Active in the company since 2025. Fredrik Blom holds a master's degree in financial economics from Stockholm University. Throughout his professional career, Fredrik has primarily worked in sales, often within entrepreneurially driven companies. He has co-founded several companies, one of them is Svenska Studenthus, a real estate company focused on rental and student housing, which merged with K2A Fastigheter prior to the company's IPO on Nasdaq Stockholm in 2019. Fredrik has extensive experience in starting companies and developing their initial cash flows. Other companies Fredrik has co-founded and served on the board of include Jeff Fastigheter and RAW Properties. Shareholding: 926,000 shares. Independent in relation to the Company and the owners.

Current shareholding is not automatically updated for the moment. Insiders no longer have obligation to report there shareholding. According to the regulatory requirements, the data shall be updated once a year.